A US multicenter retrospective cohort study in patients undergoing peritoneal dialysis or hemodialysis found that hypercalcemia (both uncorrected and albumin-corrected calcium) was predicted to increase the risk of mortality by up to 60% (13). The gene discussed is ALB; the disease is hypercalcemia disease.